|

1.48 GBq of 177Lu-AB-3PRGD2 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Peking Union Medical College Hospital1

Indications

  • Integrin αVβ3 Positive Tumors1
  • Cancer1

Other1 trial

177Lu-AB-3PRGD2 in Patients With Integrin αVβ3 Positive Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.